TR201906364T4 - Polikistik over sendromu ve bunun ilgili semptomplarının önlenmesi veya tedavisine yönelik bileşim. - Google Patents

Polikistik over sendromu ve bunun ilgili semptomplarının önlenmesi veya tedavisine yönelik bileşim. Download PDF

Info

Publication number
TR201906364T4
TR201906364T4 TR2019/06364T TR201906364T TR201906364T4 TR 201906364 T4 TR201906364 T4 TR 201906364T4 TR 2019/06364 T TR2019/06364 T TR 2019/06364T TR 201906364 T TR201906364 T TR 201906364T TR 201906364 T4 TR201906364 T4 TR 201906364T4
Authority
TR
Turkey
Prior art keywords
composition
prevention
treatment
polycystic ovary
related symptoms
Prior art date
Application number
TR2019/06364T
Other languages
English (en)
Inventor
Scapagnini Giovanni
Maria Antonio Di Marco Roberto
Mangano Katia
Longo Sormani Sonia
Original Assignee
Claride Pharma S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Claride Pharma S R L filed Critical Claride Pharma S R L
Publication of TR201906364T4 publication Critical patent/TR201906364T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/39Convolvulaceae (Morning-glory family), e.g. bindweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Mevcut buluş bir açıda, Banaba ekstraktı ( Lagerstroemia speciosa L. ), kiral veya tuz formlarından birinde inositol, Ipomoea Batatas ve fizyolojik olarak kabul edilebilir bir taşıyıcı içeren, polikistik over sendromu ve bunun ilgili semptomlarının önlenmesi ve/veya tedavisine yönelik bir bileşim ile ilgilidir. Bileşim ayrıca, lignanlar içerebilmektedir ve bir bitki özlü ürün, bir gıda takviyesi, bir diyetetik ve/veya bir besleyici ürün olabilmektedir.
TR2019/06364T 2015-11-05 2016-11-04 Polikistik over sendromu ve bunun ilgili semptomplarının önlenmesi veya tedavisine yönelik bileşim. TR201906364T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2015A005087A ITUB20155087A1 (it) 2015-11-05 2015-11-05 Composizione per prevenire o trattare la sindrome dell'ovaio policistico e la sintomatologia correlata

Publications (1)

Publication Number Publication Date
TR201906364T4 true TR201906364T4 (tr) 2019-05-21

Family

ID=55410033

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/06364T TR201906364T4 (tr) 2015-11-05 2016-11-04 Polikistik over sendromu ve bunun ilgili semptomplarının önlenmesi veya tedavisine yönelik bileşim.

Country Status (12)

Country Link
EP (1) EP3165229B8 (tr)
DK (1) DK3165229T3 (tr)
ES (1) ES2723598T3 (tr)
HR (1) HRP20190676T1 (tr)
HU (1) HUE043246T2 (tr)
IT (1) ITUB20155087A1 (tr)
LT (1) LT3165229T (tr)
PL (1) PL3165229T3 (tr)
PT (1) PT3165229T (tr)
RS (1) RS58661B1 (tr)
SI (1) SI3165229T1 (tr)
TR (1) TR201906364T4 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20163025A1 (it) 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico
CN115282176A (zh) * 2022-08-24 2022-11-04 北京彩晔健康管理有限公司 用于延缓卵巢衰老和改善多囊性卵巢综合征的组合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006069385A2 (en) * 2004-12-22 2006-06-29 Renaissance Herbs, Inc. Pharmaceutical, therapeutic, and dietary compositions derived from lagerstroemia speciosa l. plant
US8349373B1 (en) * 2011-07-25 2013-01-08 Conrad Anton Smith Dietary supplement for use in a weight loss program
CN102631516A (zh) * 2012-05-02 2012-08-15 马守云 一种治疗不孕症的药物

Also Published As

Publication number Publication date
PL3165229T3 (pl) 2019-08-30
DK3165229T3 (da) 2019-05-13
RS58661B1 (sr) 2019-06-28
EP3165229A1 (en) 2017-05-10
SI3165229T1 (sl) 2019-06-28
EP3165229B8 (en) 2019-05-22
HUE043246T2 (hu) 2019-08-28
LT3165229T (lt) 2019-05-27
EP3165229B1 (en) 2019-02-13
ITUB20155087A1 (it) 2017-05-05
ES2723598T3 (es) 2019-08-29
HRP20190676T1 (hr) 2019-05-31
PT3165229T (pt) 2019-05-28

Similar Documents

Publication Publication Date Title
SA517381819B1 (ar) التعديل المناعي
MX2017009532A (es) Uso de acidos grasos de cadena corta en prevencion de cancer.
MX2019009508A (es) Preparacion e incorporacion de co-productos en bebidas para mejorar la nutricion y atributos sensoriales.
MX2018002543A (es) Composiciones que comprenden compuestos de urolitina.
CL2016002955A1 (es) Composicion de edulcorante que comprende alulosa y un extracto de stevia; producto alimenticio o bebida que comprende la composicion edulcorante; edulcorante de mesa; uso de la composición edulcorante.
EA201791531A1 (ru) Натуральный подсластитель
MX2015012379A (es) Novedosas cepas de lactobacillus y los usos de las mismas.
MY174991A (en) Eurycoma longifolia extract and its use in enhancing and/or stimulating immune system
AR102186A1 (es) Bebida en capas
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
MX2016016995A (es) Composiciones de acido fitico, magnesio y polifenoles y su aplicacion para la prevencion de la litiasis renal oxalocalcica.
TR201908639T4 (tr) Dejeneratif göz bozukluklarının önlenmesi ve veya tedavisine yönelik safran bazlı bileşimler.
TR201906364T4 (tr) Polikistik over sendromu ve bunun ilgili semptomplarının önlenmesi veya tedavisine yönelik bileşim.
EA201791526A1 (ru) Натуральная композиция подсластителя из ло хан го
MA40645A (fr) Préparation prébiotique à base d'inuline
WO2015000053A8 (en) Enzyme formulation for use as food supplement
MX2015012771A (es) Procedimiento de tratamiento de la deficiencia de vitamina b12.
WO2016072692A3 (ko) 네크록스를 유효성분으로 함유하는 점막염 예방 또는 치료용 조성물
MX358907B (es) Capsulas para la liberacion de aroma.
MX2019000106A (es) Productos de masa fritos.
RU2013110923A (ru) Состав для приготовления фитоджема (варианты)
MX2018001848A (es) Bebida con alto contenido de solidos que comprende beta-manasa.
MY188896A (en) Methods and compositions for reducing digestive/absorptive rates and ratio of food/drinks or reducing a digestive solution
MX2018002531A (es) Metodos para aumentar la absorcion de vitaminas liposolubles en la alimentacion.
MX363686B (es) Capsulas de aceite de cafe.